- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00809081
Early Enteral Feeding After Pylorus Preserving Pancreatoduodenectomy
A Prospective, Randomized Trial of Early Enteral Feeding After Pylorus Preserving Pancreatoduodenectomy
Pancreaticoduodenectomy is associated with a high incidence of postoperative complications. These postoperative complications could delay postoperative resumption of adequate oral intake. Clinical study on postoperative feeding after pancreaticoduodenectomy is very limited. Method of Nutritional support (Enteral feeding or total parenteral support)after pancreaticoduodenectomy is controversial.
- To evaluate whether early enteral nutrition may be a suitable alternative to total parenteral nutrition
- To evaluate whether enteral feeding improve nutritional status after pancreaticoduodenectomy
Study Overview
Status
Intervention / Treatment
Detailed Description
Pancreaticoduodenectomy is associated with a high incidence of postoperative complications. These postoperative complications could delay postoperative resumption of adequate oral intake. The use of TPN significantly increases postoperative complications, especially those associate with infections. However, method of Nutritional support (Enteral feeding or total parenteral support)after pancreaticoduodenectomy is controversial.
- To evaluate whether early enteral nutrition may be decreased the postoperative complications
- To evaluate whether enteral feeding improve nutritional status after pancreaticoduodenectomy
- To determine the optimal method for postoperative nutritional support
Study Type
Enrollment (Anticipated)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of
- Recruiting
- Yongdong Severance Hospital
-
Contact:
- Dong Sup Yoon, MD, PhD
- Phone Number: +82-2-2019-2444
- Email: yds6110@yuhs.ac
-
Contact:
- Joon Seong Park, MD
- Phone Number: +82-2-2019-3375
- Email: jspark330@yuhs.ac
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Periampullar carcinoma
- Pancreaticoduonectomy
- KARNOFSKY PERFORMANCE SCALE > 70
- No history of Major operation
Exclusion Criteria:
- Creatinine level>3mg/L
- Ascitis/portal hypertension
- New York Heart Association class>3
- COPD
- Preoperative Radiotheraly/chemotherapy
- Unresectable primary cancer
- Palliative surgery
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
OTHER: 1
1. Enteral Feeding
|
Enteral Feeding : 20ml/hr on POD1
Other Names:
|
|
NO_INTERVENTION: 2
Total Parental support
|
Enteral Feeding : 20ml/hr on POD1
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To evaluate the impact of early postoperative enteral feeding
Time Frame: Postoperative 21 days
|
Postoperative 21 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To evaluate the nutritional status
Time Frame: Postoperative 6 months
|
Postoperative 6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Dong Sup Yoon, MD,PhD, Yonsei University
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Neoplasms by Histologic Type
- Neoplasms
- Neoplasms by Site
- Adenocarcinoma
- Carcinoma
- Neoplasms, Glandular and Epithelial
- Endocrine System Diseases
- Digestive System Neoplasms
- Endocrine Gland Neoplasms
- Biliary Tract Diseases
- Pancreatic Diseases
- Bile Duct Diseases
- Biliary Tract Neoplasms
- Pancreatic Neoplasms
- Cholangiocarcinoma
- Bile Duct Neoplasms
Other Study ID Numbers
- EN Vs PN
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bile Duct Cancer
-
National Cancer Institute (NCI)RecruitingBile Duct Cancer | Biliary Cancer | Cancer of the Bile DuctUnited States
-
Mayo ClinicNational Comprehensive Cancer NetworkCompletedStage III Gallbladder Cancer AJCC v8 | Stage IIIA Gallbladder Cancer AJCC v8 | Stage IIIB Gallbladder Cancer AJCC v8 | Refractory Gallbladder Carcinoma | Stage IV Gallbladder Cancer AJCC v8 | Stage IV Distal Bile Duct Cancer AJCC v8 | Stage IV Intrahepatic Bile Duct Cancer AJCC v8 | Stage IVB Gallbladder... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Extrahepatic Bile Duct Cancer | Unresectable Extrahepatic Bile Duct Cancer | Liver and Intrahepatic Biliary Tract CancerUnited States
-
Insel Gruppe AG, University Hospital BernSwiss Cancer LeagueRecruiting
-
Innovative Digestive Health Education and Research...NinePoint MedicalUnknownCholangiocarcinoma | Bile Duct Cancer | Primary Sclerosing Cholangitis | Bile Duct Diseases | Pancreatic Ductal Adenocarcinoma | Pancreas Cancer | Bile Duct Neoplasms | Biliary Stricture | Bile Duct Obstruction | Bile Duct Obstruction, Extrahepatic | Pancreatic Duct Stricture | Bile Duct Lesions | Bile Duct Neoplasms... and other conditionsUnited States
-
UNICANCERCompletedLiver Cancer | Gallbladder Cancer | Extrahepatic Bile Duct CancerFrance
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent Extrahepatic Bile Duct Cancer | Recurrent Gallbladder Cancer | Unresectable Extrahepatic Bile Duct Cancer | Unresectable Gallbladder Cancer | Cholangiocarcinoma of the Extrahepatic Bile Duct | Cholangiocarcinoma of the GallbladderUnited States, Canada
-
National Cancer Institute (NCI)TerminatedMalignant Neoplasm | Recurrent Extrahepatic Bile Duct Cancer | Recurrent Gallbladder Cancer | Unresectable Extrahepatic Bile Duct Cancer | Unresectable Gallbladder Cancer | Adenocarcinoma of the Gallbladder | Adenocarcinoma of the Extrahepatic Bile DuctUnited States
-
Institut Paoli-CalmettesCompletedNonresectable Bile Duct CancerFrance
-
Instituto Ecuatoriano de Enfermedades DigestivasUniversity of Sao Paulo; Universitair Ziekenhuis Brussel; The Methodist Hospital... and other collaboratorsCompletedCommon Bile Duct Neoplasms | Non-Neoplastic Bile Duct DisorderUnited States, Ecuador, Belgium, Brazil
Clinical Trials on Enteral Feeding and Total Parental Support
-
Lady Hardinge Medical CollegeCompletedEnteral Feeding Intolerance | Very Preterm Maturity of InfantIndia
-
Lady Hardinge Medical CollegeCompletedNutrition of Preterm InfantsIndia
-
Centre Hospitalier Departemental VendeeInstitut National de la Santé Et de la Recherche Médicale, France; Ministry... and other collaboratorsCompletedShock | Acute Respiratory FailureFrance
-
University Hospital, LimogesCompletedMechanically Ventilated PatientsFrance
-
Ziekenhuis Oost-LimburgFederaal Kenniscentrum voor Gezondheidszorg, BelgiumNot yet recruitingCritical Illness | Intensive Care (ICU)Belgium, Netherlands
-
University of GlasgowNHS Lothian; NHS Tayside; NHS Grampian; NHS Lanarkshire; NHS Greater Clyde and Glasgow and other collaboratorsRecruitingCrohn's Disease (CD)United Kingdom
-
Peking Union Medical College HospitalRecruitingCritical Illness | Intestinal Ischemia | Hemodynamics | Enteral Nutrition Feeding | Ultrasonography, DopplerChina
-
Bursa Yuksek Ihtisas Training and Research HospitalEnrolling by invitationGastric Emptying | Enteral Nutrition (Food for Special Medical Purposes)Turkey (Türkiye)
-
Peking UniversityRecruitingGrowth RetardationChina
-
Jinling Hospital, ChinaNot yet recruiting